Search | Page 36 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Pharmacokinetic Guided Dose Escalation and Dose Confirmation With Oral Decitabine and Oral CDAi in Patients With MDS

    For more details on this clinical trial, including contact information, please see this trial’s listing on ... stage the selected dose will be confirmed and evaluated for clinical activity, including response rate. ...

    Clinical Trial last updated 04/27/2016 - 2:05pm.

  2. A Study of CC-90002 in Subjects With Acute Myeloid Leukemia (AML) and High-risk Myelodysplastic Syndrome (MDS)

    For more details on this clinical trial, including contact information, please see this trial’s listing on ... Phase 1 dose escalation (Part A) and expansion (Part B), clinical study of CC-90002, administered by intravenous (IV) infusion, in ...

    Clinical Trial last updated 04/27/2016 - 1:31pm.

  3. A Combination Study of PF-04449913 and Azacitidine In 1st Line MDS, AML and CMML Patients

    For more details on this clinical trial, including contact information, please see this trial’s listing on ... dysplasia, and Chronic Myelomonocytic Leukemia (CMML). This clinical study includes two components: (a) a Phase 1b safety lead in and (b) a ...

    Clinical Trial last updated 04/27/2016 - 1:20pm.

  4. Safety and Efficacy of BL-8040 for the Mobilization of Donor Hematopoietic

    For more details on this clinical trial, including contact information, please see this trial’s listing on ... Any medical condition which, in the opinion of the clinical investigator, would interfere with the evaluation of the patient. ...

    Clinical Trial last updated 04/29/2016 - 4:33pm.

  5. Ipilimumab in Treating Patients With Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia

    For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov: ...

    Clinical Trial last updated 04/21/2016 - 9:26am.

  6. Conditioning Regimen and the Transplantation of Unrelated Donor Umbilical Cord Blood in Patients With Hematologic Malignancies.

    For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov: ...

    Clinical Trial last updated 04/29/2016 - 3:51pm.

  7. Lenalidomide After Allo-Hematopoietic Cell Transplant (HCT) in Acute Myelogenous Leukemia (AML) and Myelodysplastic Syndromes (MDS) Subjects With Minimal Residual Disease (UF-BMT-MRD-101)

    For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov: ...

    Clinical Trial last updated 04/29/2016 - 2:38pm.

  8. Safety and Tolerability of HSC835 in Patients With Hematological Malignancies

    For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov: ...

    Clinical Trial last updated 04/29/2016 - 2:14pm.

  9. The Rapid Study: Randomized Phase II Study To Expedite Allogeneic Transplant With Immediate Haploidentical Plus Unrelated Cord Donor Search Versus Matched Unrelated Donor Search For AML And High-Risk MDS Patients

    For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov: ...

    Clinical Trial last updated 04/29/2016 - 2:02pm.

  10. KIR Favorable Mismatched Haplo Transplant and KIR Polymorphism in ALL/AML/MDS Allo-HCT Children

    For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov: ...

    Clinical Trial last updated 04/29/2016 - 2:01pm.